Verified Peptide ReviewLast reviewed: 1 April 2026
Compound Profile · Cognitive
Cerebrolysin
Cerebrolysin is a standardised peptide-enriched extract derived from porcine brain, used clinically in some jurisdictions for stroke, dementia and cognitive impairment.
LegalPrescriptionEvidenceModerateHuman useApproved
7.6/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Approved in several jurisdictions for cognitive and neurological indications. Evidence is stronger in some markets than others.
Reality check
What this isn't
- Moderate evidence — replication still building
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full Cerebrolysin review
A complex mixture of peptides and amino acids derived from porcine brain.
Proposed to support synaptic function and neuroprotection, administered intravenously or intramuscularly.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.